MCK

$994.581.40%13.70

Mckesson Corp (MCK)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$980.88

Offen:

$1,006.29

24-Stunden-Volumen:

763,209

Relatives Volumen:

1.10

Marktkapitalisierung:

$115.96B

Einnahmen:

$403.43B

Nettoeinkommen (Verlust:

$5.10B

KGV:

25.86

EPS:

$38.47

Netto-Cashflow:

$5.41B

1W Leistung:

+0.17%

1M Leistung:

+10.23%

6M Leistung:

+22.18%

1Y Leistung:

+22.58%

1-Tages-Spanne:

$0.00$0.00

1-Wochen-Bereich:

$954.05$1,016.92

52-Wochen-Spanne:

$723.68$1,030.27

Mckesson Corp Aktie (MCK) Unternehmensprofil

Firmenname

Mckesson Corp

Sektor

Healthcare

Branche

Medical Distribution

Telefon

972-446-4800

Adresse

6555 STATE HIGHWAY 161, IRVING, TX, USA

Mitarbeiter

43,000

@McKesson

Nächster Verdiensttermin

2026-11-04

Neueste SEC-Einreichungen

SEC

MCK-Diskussionen auf X

MCK vs. COR, CAH, HSIC, AHG vergleichen

Aktien	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MCK Mckesson Corp	$115.96B	$403.43B	$5.10B	$5.41B	$38.47
COR Cencora Inc	$63.13B	$328.68B	$2.55B	$1.56B	$13.03
CAH Cardinal Health Inc	$58.00B	$250.74B	$1.55B	$4.39B	$6.54
HSIC Henry Schein Inc	$9.46B	$13.38B	$418.00M	$391.00M	$3.31
AHG Akso Health Group Adr	$1.08B	$14.85M	-$136.07M	$7.25M	-$0.4726

Mckesson Corp Aktie (MCK) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-08-19	Eingeleitet	RBC Capital Mkts	Sector Perform
2026-04-28	Eingeleitet	William Blair	Outperform
2025-12-09	Eingeleitet	Barclays	Overweight
2024-12-04	Resumed	Mizuho	Neutral
2024-11-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-09-24	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-09-05	Bestätigt	Leerink Partners	Outperform
2024-08-08	Bestätigt	Mizuho	Neutral
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-14	Eingeleitet	Wells Fargo	Equal Weight
2023-03-31	Eingeleitet	Citigroup	Buy
2022-08-22	Resumed	Morgan Stanley	Overweight
2022-07-06	Herabstufung	Argus	Buy → Hold
2022-06-07	Hochstufung	Deutsche Bank	Hold → Buy
2022-04-01	Resumed	Credit Suisse	Outperform
2022-02-04	Herabstufung	Deutsche Bank	Buy → Hold
2022-01-07	Hochstufung	Credit Suisse	Neutral → Outperform
2021-11-02	Bestätigt	Barclays	Overweight
2021-11-02	Bestätigt	BofA Securities	Buy
2021-11-02	Bestätigt	Evercore ISI	Outperform
2021-11-02	Bestätigt	Jefferies	Buy
2021-03-30	Hochstufung	Argus	Hold → Buy
2020-11-02	Hochstufung	Barclays	Equal Weight → Overweight
2020-08-04	Hochstufung	Deutsche Bank	Hold → Buy
2020-05-22	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-05-15	Hochstufung	UBS	Neutral → Buy
2020-04-23	Resumed	Credit Suisse	Neutral
2020-03-18	Hochstufung	Goldman	Neutral → Buy
2020-03-13	Hochstufung	Guggenheim	Neutral → Buy
2020-02-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-01-10	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-08-05	Herabstufung	Wolfe Research	Outperform → Peer Perform
2019-07-22	Eingeleitet	Guggenheim	Neutral
2019-01-17	Eingeleitet	UBS	Neutral
2018-10-26	Bestätigt	Barclays	Equal Weight
2018-07-20	Herabstufung	Robert W. Baird	Outperform → Neutral
2018-05-29	Bestätigt	Leerink Partners	Mkt Perform
2018-03-08	Eingeleitet	Barclays	Equal Weight
2018-02-27	Resumed	BofA/Merrill	Buy
2018-02-02	Bestätigt	Mizuho	Neutral
2018-01-24	Hochstufung	Jefferies	Hold → Buy

Finanzdaten der Mckesson Corp-Aktie (MCK)

Zeitraum	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Enddatum des Zeitraums	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Revenue USD (M)	403,430.00	359,051.00	308,951.00	276,711.00	263,966.00
Cost of revenue USD (M)	388,880.00	345,728.00	296,123.00	264,353.00	250,836.00
Gross profit USD (M)	14,550.00	13,323.00	12,828.00	12,358.00	13,130.00
Operating expenses USD (M)	8,338.00	8,901.00	8,919.00	7,977.00	11,092.00
Operating income USD (M)	6,212.00	4,422.00	3,909.00	4,381.00	2,038.00
Income before tax USD (M)	6,201.00	4,359.00	3,789.00	4,630.00	1,928.00
Income tax expense USD (M)	1,102.00	878.00	629.00	905.00	636.00
Net income USD (M)	5,099.00	3,481.00	3,160.00	3,722.00	1,287.00
Basic EPS USD/shares	38.55	25.86	22.54	25.23	7.32
Diluted EPS USD/shares	38.38	25.72	22.39	25.03	7.23
Basic weighted shares shares (M)	123.60	127.40	133.20	141.10	152.30
Diluted weighted shares shares (M)	124.10	128.10	134.10	142.20	154.10
Selling, general and administrative USD (M)	8,096.00	8,507.00	8,657.00	7,776.00	10,537.00

Mckesson Corp-Aktie (MCK) Insiderhandel

Fraga FranciscoOct 15 '26
Officer
Transaktion
Proposed Sale
Kosten
$995.17
#Aktien
801
Wert ($)
797,129
#Aktien Gesamt
0
Rutledge Napoleon B JRSep 08 '26
SVP, Controller & CAO
Transaktion
Sale
Kosten
$891.45
#Aktien
111
Wert ($)
98,951
#Aktien Gesamt
521
Lerman Bradley EAug 10 '26
Director
Transaktion
Sale
Kosten
$892.33
#Aktien
301
Wert ($)
268,590
#Aktien Gesamt
0
Lerman Bradley EAug 10 '26
Director
Transaktion
Proposed Sale
Kosten
$892.32
#Aktien
301
Wert ($)
268,589
#Aktien Gesamt
0
Vitalone Britt J.Aug 03 '26
Former Officer
Transaktion
Proposed Sale
Kosten
$843.31
#Aktien
7,925
Wert ($)
6,683,192
#Aktien Gesamt
0
TYLER BRIAN S.Jul 07 '26
Officer
Transaktion
Proposed Sale
Kosten
$793.56
#Aktien
8,463
Wert ($)
6,715,898
#Aktien Gesamt
0
TYLER BRIAN S.Jul 07 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$793.56
#Aktien
8,463
Wert ($)
6,715,898
#Aktien Gesamt
5,919
TYLER BRIAN S.Jun 17 '26
Officer
Transaktion
Proposed Sale
Kosten
$775.13
#Aktien
8,463
Wert ($)
6,559,925
#Aktien Gesamt
0
TYLER BRIAN S.Jun 17 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$775.13
#Aktien
8,463
Wert ($)
6,559,925
#Aktien Gesamt
14,382
TYLER BRIAN S.Jun 09 '26
Officer
Transaktion
Proposed Sale
Kosten
$763.00
#Aktien
4,929
Wert ($)
3,760,827
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Fraga Francisco	Officer	Oct 15 '26	Proposed Sale	$995.17	801	797,129	0
Rutledge Napoleon B JR	SVP, Controller & CAO	Sep 08 '26	Sale	$891.45	111	98,951	521
Lerman Bradley E	Director	Aug 10 '26	Sale	$892.33	301	268,590	0
Lerman Bradley E	Director	Aug 10 '26	Proposed Sale	$892.32	301	268,589	0
Vitalone Britt J.	Former Officer	Aug 03 '26	Proposed Sale	$843.31	7,925	6,683,192	0
TYLER BRIAN S.	Officer	Jul 07 '26	Proposed Sale	$793.56	8,463	6,715,898	0
TYLER BRIAN S.	Chief Executive Officer	Jul 07 '26	Sale	$793.56	8,463	6,715,898	5,919
TYLER BRIAN S.	Officer	Jun 17 '26	Proposed Sale	$775.13	8,463	6,559,925	0
TYLER BRIAN S.	Chief Executive Officer	Jun 17 '26	Sale	$775.13	8,463	6,559,925	14,382
TYLER BRIAN S.	Officer	Jun 09 '26	Proposed Sale	$763.00	4,929	3,760,827	0

Mckesson Corp Aktie (MCK) Neueste Nachrichten

Oct 29, 2026

McKesson (MCK) Stock Could Be 43% Undervalued Despite Strong Cash Flow Doubts - Yahoo Finance

Oct 29, 2026

Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy? - Zacks Investment Research

Oct 29, 2026

Oct 28, 2026

McKesson stock may move 6.2% on upcoming earnings report - Investing.com

Oct 28, 2026

McKesson stock may move 6.2% on upcoming earnings report By Investing.com - Investing.com Australia

Oct 28, 2026

Oct 27, 2026

Cardinal Health, McKesson awarded $2.7B and $741.5M DLA contracts respectively - TipRanks

Oct 27, 2026

McKesson (MCK) Stock Dips While Market Gains: Key Facts - Zacks Investment Research

Oct 27, 2026

McKesson (MCK) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Oct 27, 2026

Here's Why McKesson (MCK) is a Strong Momentum Stock - Zacks Investment Research

Oct 27, 2026

Oct 26, 2026

UBS lifts target to USD 1,200 for McKesson stock - ad-hoc-news.de

Oct 26, 2026

McKesson Corporation (NYSE:MCK) Eases 1.14% to USD 1,000.77, the Highest Share Price in This Group of Stocks - Kalkine India

Oct 26, 2026

Oct 25, 2026

McKesson (MCK) Stock Dips While Market Gains: Key Facts - Zacks Investment Research

Oct 21, 2026

McKesson stock: UBS raises target to USD 1,200 for McKesson stock - AD HOC NEWS

Oct 21, 2026

Mckesson Corp - Declares QTRLY Dividend Of $0.94 Per Share - TradingView

Oct 21, 2026

McKesson Corporation Announces Quarterly Dividend, Payable on January 4, 2027 - marketscreener.com

Oct 21, 2026

McKesson declares 94 cent quarterly dividend By Investing.com - Investing.com India

Oct 21, 2026

McKesson declares 94 cent quarterly dividend By Investing.com - Investing.com Canada

Oct 21, 2026

Is Trending Stock McKesson Corporation (MCK) a Buy Now? - Zacks Investment Research

Oct 21, 2026

Is Trending Stock McKesson Corporation (MCK) a Buy Now? - Yahoo Finance

Oct 21, 2026

McKesson Corporation Declares Quarterly Dividend - Yahoo Finance

Oct 21, 2026

9 Green Days In A Row: McKesson Stock Is Up 13% - Trefis

Oct 21, 2026

Oct 20, 2026

Would You Have Held McKesson Stock All The Way Up? - Trefis

Oct 20, 2026

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 20, 2026

McKesson (MCK) Outperforms Broader Market: What You Need to Know - Zacks Investment Research

Oct 20, 2026

McKesson (MCK) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Oct 20, 2026

Europe Electronic Health Record (EHR) Market Size, Share, Trends, and Forecast, 2021 - 2031 | AI and Cloud Adoption Drive 9.9% CAGR, Creating a US$ 15.37 Billion Opportunity - GlobeNewswire Inc.

Oct 20, 2026

Leerink raises target for McKesson stock from USD 1,030 to USD 1,070 - ad-hoc-news.de

Oct 20, 2026

McKesson EVP, CIO and CTO Francisco Fraga sells $797,128 in stock - Investing.com India

Oct 20, 2026

McKesson Stock Rides An 8-Day Winning Streak To An 11% Gain - Trefis

Oct 20, 2026

Oct 19, 2026

McKesson (MCK) Stock Could Stay Reasonable Despite Its 400% Run - Simply Wall Street

Oct 19, 2026